연구

연구업적

최근 5년 연구업적 현황
연도 2024년 2023년 2022년 2021년 2020년
SCI 논문
발표편수
책임 179편 173편 163편 184편 135편
공동 147편 120편 115편 136편 168편
합계 326편 293편 278편 320편 303편
1347. Peri-engraftment syndrome in allogeneic hematopoietic SCT.
Hong KT1, Kang HJ, Kim NH, Kim MS, Lee JW, Kim H, Park KD, Shin HY, Ahn HS.
Bone Marrow Transplant. 2013 Apr;48(4):523-8. doi: 10.1038/bmt.2012.171. Epub 2012 Sep 24. Link
1346. Differential clinicopathologic features in microsatellite-unstable gastric cancers with and without MLH1 methylation.
Kim KJ, Lee TH, Cho NY, Yang HK, Kim WH, Kang GH.
Hum Pathol. 2013 Jun;44(6):1055-64. doi: 10.1016/j.humpath.2012.09.009. Epub 2012 Dec 23. Link
1345. Epigenetic alterations in colorectal cancer: the CpG island methylator phenotype.
Bae JM, Kim JH, Kang GH.
Histol Histopathol. 2013 May;28(5):585-95. Epub 2013 Jan 23. Link
1344. Subsets of microsatellite-unstable colorectal cancers exhibit discordance between the CpG island methylator phenotype and MLH1 methylation status.
Kim JH, Rhee YY, Bae JM, Kwon HJ, Cho NY, Kim MJ, Kang GH.
Mod Pathol. 2013 Jul;26(7):1013-22. doi: 10.1038/modpathol.2012.241. Epub 2013 Feb 1. Link
1343. Down-regulation of dual-specificity phosphatase 5 in gastric cancer by promoter CpG island hypermethylation and its potential role in carcinogenesis.
Shin SH, Park SY, Kang GH.
Am J Pathol. 2013 Apr;182(4):1275-85. doi: 10.1016/j.ajpath.2013.01.004. Epub 2013 Feb 10. Link
1342. Prognostic implication of the CpG island methylator phenotype in colorectal cancers depends on tumour location.
Bae JM, Kim JH, Cho NY, Kim TY, Kang GH.
Br J Cancer. 2013 Aug 20;109(4):1004-12. doi: 10.1038/bjc.2013.430. Epub 2013 Jul 30. Link
1341. Loss of CDX2/CK20 expression is associated with poorly differentiated carcinoma, the CpG island methylator phenotype, and adverse prognosis in microsatellite-unstable colorectal cancer.
Kim JH, Rhee YY, Bae JM, Cho NY, Kang GH.
Am J Surg Pathol. 2013 Oct;37(10):1532-41. doi: 10.1097/PAS.0b013e31829ab1c1. Link
1340. One-step detection of circulating tumor cells in ovarian cancer using enhanced fluorescent silica nanoparticles.
Kim JH1, Chung HH, Jeong MS, Song MR, Kang KW, Kim JS.
Int J Nanomedicine. 2013;8:2247-57. doi: 10.2147/IJN.S45059. Epub 2013 Jun 21. Link
1339. CD15+/CD16low human granulocytes from terminal cancer patients: granulocytic myeloid-derived suppressor cells that have suppressive function.
Choi J, Suh B, Ahn YO, Kim TM, Lee JO, Lee SH, Heo DS.
Tumour Biol. 2012 Feb;33(1):121-9. Link
1338. Influence of chemotherapy on nitric oxide synthase, indole-amine-2,3-dioxygenase and CD124 expression in granulocytes and monocytes of non-small cell lung cancer.
Sim SH, Ahn YO, Yoon J, Kim TM, Lee SH, Kim DW, Heo DS.
Cancer Sci. 2012 Feb;103(2):155-60. Link